In July 2007, Dr. Mark B. McClellan became the Director of the Engelberg Center for Health Care Reform at the Brookings Institution, where he studies ways to provide practical solutions for access, quality and financing challenges facing the U. S. health care system.
 
Dr. McClellan has a highly distinguished record in public service and in academic research. He is the former administrator for the Centers for Medicare and Medicaid Services (2004-2006) and the former commissioner of the Food and Drug Administration (2002-2004). He also served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House (2001–2002). In these positions, he developed and implemented major reforms in health policy. These include:

• The Medicare prescription drug benefit and other innovative coverage options, including the move from indemnity insurance to personalized, prevention-oriented care;
• Innovative approaches to coverage in Medicaid and the State Children’s Health Insurance Program, including roadmaps that states have used to update and expand coverage and the “Money Follows the Person” initiatives in long-term care;
• The development of the FDA’s Critical Path initiative, regulatory reforms to modernize pharmaceutical manufacturing, efficient risk-management methods to better address safety issues, and reforms to speed the approval of low-cost generic medicines and improve the availability of safe effective treatments; and
• Public-private initiatives to develop better information on the quality and cost of care, and steps to help consumers and providers use this information to improve care, including performance-based provider payment reforms, and Health Savings Accounts and Health Reimbursement Arrangements.